# Circulating Cell-Free Mitochondrial DNA as a Novel Biomarker for Intra-Amniotic Infection in Obstetrics: A Pilot Trial

**Authors:** Sebastian Zeiner, Peter Wohlrab, Ingo Rosicky, Regina Patricia Schukro, Klaus Ulrich Klein, Johann Wojta, Walter Speidl, Herbert Kiss, Dana Anaïs Muin

PMC · DOI: 10.3390/jcm13164616 · 2024-08-07

## TL;DR

This study explores cell-free mitochondrial DNA in maternal blood as a potential biomarker for detecting intra-amniotic infection during pregnancy.

## Contribution

The study introduces circulating cell-free mitochondrial DNA as a novel biomarker for diagnosing intra-amniotic infection.

## Key findings

- Mean plasma mtDNA levels were significantly higher in the IAI group compared to controls.
- Postpartum placental mtDNA levels were also significantly elevated in the IAI group.
- These findings suggest mtDNA could be a valuable biomarker for IAI prediction.

## Abstract

Background/Objectives: Intra-amniotic infection (IAI) is a rare but serious condition with potential complications such as preterm labor and intrauterine fetal death. Diagnosing IAI is challenging due to varied clinical signs. Oxidative stress and mitochondrial dysfunction have been hypothesized to evolve around IAI. This study focused on measuring circulating mtDNA levels, a proposed biomarker for mitochondrial dysfunction, in maternal serum and placenta of women with confirmed IAI and healthy controls. Methods: 12 women with confirmed IAI (IAI group) were enrolled following premature preterm rupture of the membranes (PPROM) and compared to 21 healthy women (control group). Maternal blood was obtained two weeks pre-partum and peripartum; furthermore, postpartum placental blood was taken. In the IAI group, maternal blood was taken once weekly until delivery as well as peripartum, as was placental blood. Circulating cell-free mtDNA was quantified by real-time quantitative PCR. Results: Upon admission, in the IAI group, mean plasma mtDNA levels were 735.8 fg/μL compared to 134.0 fg/μL in the control group (p < 0.05). After delivery, in the IAI group, mean mtDNA levels in the placenta were 3010 fg/μL versus 652.4 fg/μL (p < 0.05). Conclusions: Circulating cell-free mtDNA could serve as a valuable biomarker for IAI prediction and diagnosis. Future research should establish reference values for sensitivity in predicting IAI.

## Linked entities

- **Diseases:** intra-amniotic infection (MONDO:0000409), intrauterine fetal death (MONDO:0041526)

## Full-text entities

- **Diseases:** PPROM (MESH:C563032), intrauterine fetal death (MESH:D005313), preterm labor (MESH:D007752), IAI (MESH:D000652), mitochondrial dysfunction (MESH:D028361)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11354521/full.md

---
Source: https://tomesphere.com/paper/PMC11354521